Columnist Connie Chandler writes of a generational disconnect with new SMA patients, but says living fully must remain their ...

Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...

Nearly all children with spinal muscular atrophy who started on Evrysdi before symptom onset are walking after three years, ...

Imagine a child born in a family with a rare disease, whose treatment would cost more than 17 crore for a single dose. The ...

With this judgment, Natco Pharma can now sell the Spinal Muscular Atrophy treatment drug for ₹15,900 compared to the previous ...

CHENNAI: The Supreme Court of India on Friday dismissed an appeal filed by Swiss drugmaker F. Hoffmann-La Roche AG, which ...

Three-year-old Meher from Noida was diagnosed with Turner Syndrome at PGICH using QF-PCR, a first for the institute. Early ...

The Supreme Court upheld Delhi HC's interim order allowing Natco Pharma to manufacture and sell a generic version of Roche's ...

Roche has moved the Supreme Court challenging a Delhi HC order that allowed Natco Pharma to manufacture and sell a generic ...

The Supreme Court has given the go-ahead to Natco Pharma for launching its generic version of Risdiplam in India, dismissing ...

Roche sued Natco in early 2024 after learning that the Hyderabad-based company plans to launch a lower-cost generic version ...

Supreme Court dismisses Roche's petition, allowing NATCO Pharma to sell affordable spinal muscular atrophy drug in India.